Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat

American Journal of Hypertension

Volumn 1, Issue 1, 1988, Pages 5-10

  Cooper, M E ^a   Allen, T J ^a   Macmillan, P ^a   Bach, L ^a   Ferums, G ^a   Doyle, A E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Albuminuria; Diabetes; Hypertension; Nephropathy

Indexed keywords

ENALAPRIL; STREPTOZOCIN;

ANIMAL EXPERIMENT; DIABETES MELLITUS; HYPERTENSION; KIDNEY DISEASE; NONHUMAN; PROTEINURIA; RAT;

ALBUMINURIA; ANALYSIS OF VARIANCE; ANIMAL; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; ENALAPRIL; GLOMERULAR FILTRATION RATE; HYPERTENSION; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; STREPTOZOCIN; TIME FACTORS;

EID: 0023894806     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/1.1.5     Document Type: Article

References (22)

1. Mogensen C.E: Longterm antihypertensive treatment inhibiting progression diabetic nephropathy. Br Med J 1982;285:685-688.
2. Parving H.H, Anderser A.R, Smidt U.M, et al: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 1987;294:1443-1447.
3. Bjorck S, Nyberg G, Mulec H, et al: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 1986;293:471-474.
4. Bunag R.D: Validation in awake rats of a rail-cuff method for measuring systolic pressure. J Appl Physiol 1973; 34:279-282.
5. Harrap S.B, Nicolaci J.A, Doyle A.E: Persistent effects on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with Perindopril. Clin Exp Pharmacol Physiol 1986, 13:753-765.
6. Cooper M.E, Allen T.J, Jerums G, et al: Accelerated progression of diabetic nephropathy in the spontaneously hypertensive Streptozotocin diabetic rat. Clin Exp Pharmacol Physiol 1986;13:655-662.
7. Viberti G.C, Jarret R.J, Mahmud U, et al: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;1:1430-1432.
8. Schmidt F.H: Enzymatic determination of glucose and fructose simultaneously. Klin Woch 1961;39:1244-1247.
9. Bryan E.W, Jarchow R.C, Maher J.F: Measurement of glomerular filtration rate in small animals without urine collection. J Lab Clin Med 1972;80:845-856.
10. Wustenberg P.W, Roman W, Bottcher M, et al: Vergleichende Wertigkeitseinschatzung monokompar-timenteller Auswertverfahren der 99m-Tc-Diathyl- kentriaminpentaessigsaure-Clearance mit fallendem Indikator-Plasmaspiegel unter besonderer Berucksichtigung langer Untersuchungszeiten. Biomed Biochim Acta 1983;42:547-559.
11. Jensen E.B, Gundersen H.J.G, Osterby R: Determination of membrane thickness distribution from othogonal intercepts. J Microsc (Oxford) 1979;115:19-33.
12. Mauer S.M, Steffes M.W, Ellis E.N, et al: Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143-1155.
13. Wallenstein S, Zucker C.L, Fleiss J.L: Some statistical methods useful in circulation research. Circ Res 1980; 47:1-9.
14. Bank N, Klose R, Aynedjian H.S, et al: Evidence against increased glomerular pressure initiating diabetic nephropathy. Kidney Int 1987;31:898-905.
15. Brenner B.M, Hostetter T.H, Humes H.D: Molecular basis of proteinuria of glomerular origin. N Engl J Med 1978; 298:826-833.
16. Bradford M.M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem 1976; 72:248-254.
17. Rabkin R, Peterson J, Kitaji J, et al: Effect of antihypertensive therapy on the kidney in spontaneously hypertensive rats with diabetes. Kidney Int 1984;25:205.
18. Zatz R, Dunn B.R, Meyer T.W, et al: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77:1925-1930.
19. Anderson S, Rennke H.G, Brenner B.M: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986, 77:1993- 2000.
20. Dworkin L, Grosser M, Feiner H, et al: Both converting enzyme inhibitors (CEI) and vasodilators reduce glomerular capillary pressure and injury in uninephrectomised spontaneously hypertensive rats. Kidney Int 1987; 31:383.
21. Zatz R, Gianella-Neto D, Cavaleiro A.M.S, et al: Lowering of blood pressure with Hydralazine does not prevent albuminuria in diabetic rats. Kidney Int 1987;31:395.
22. Marre M, Leblanc H, Suarez L, et al: Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 1987;294:1448-1452.